Here, by combined utilization of bioinformatic prediction, reporter assay, qRT-PCR and Western blot, we validated that XIAP, which exerts a critical role as an antagonist of cell apoptosis, is a novel direct target of miR-137 in GBM. This evidence concerns the gene XIAP and glioblastoma.